Fentanyl orally-dissolving film - NAL Pharma

Drug Profile

Fentanyl orally-dissolving film - NAL Pharma

Alternative Names: NAL 1239

Latest Information Update: 12 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator NAL Pharma
  • Class General anaesthetics; Opioid analgesics; Piperidines; Small molecules
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Clinical Phase Unknown Cancer pain

Most Recent Events

  • 12 Dec 2016 Chemical structure information added
  • 29 Nov 2016 Fentanyl orally-dissolving film - NAL Pharma is available for licensing as of 29 Nov 2016. http://www.nalpharma.com/licensing.php?id=4&lang=en
  • 29 Nov 2016 Clinical trials in Cancer pain (Sublingual)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top